Skip to content

S1 Ep4: OT Roundup Ep. 4: 3 FDA approvals, Duravyu LUCIA miss, brepocitinib, GLP-1 and DME

October 30, 2026 · 18 min

Show notes

This edition of OT Roundup covers 3 FDA approvals announced on a single day, a second phase 3 miss for Duravyu in wet age-related macular degeneration (AMD) with Veeral Sheth, MD, positive phase 3 results for brepocitinib in noninfectious uveitis, and registry data on GLP-1 receptor agonists and anti-VEGF treatment in diabetic macular edema (DME).

All episodes of EyePod

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.